• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   2010-2019  
Title Created Date
Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis 13 July 2018
Somatostatin Octapeptide Inhibits Cell Invasion and Metastasis in Hepatocellular Carcinoma Through PEBP1 12 July 2018
Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells 12 July 2018
Expression of Somatostatin Type-2 and -4 Receptor and Correlation with Histological Type in Breast Cancer 10 July 2018
Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice 06 July 2018
The Biological Activities of Vitamin D and Its Receptor in Relation to Calcium and Bone Homeostasis, Cancer, Immune and Cardiovascular Systems, Skin Biology, and Oral Health 06 July 2018
Targeting antioxidants for cancer therapy 04 July 2018
All-trans-retinoic acid promotes iodine uptake via up- regulating the sodium iodide symporter in medullary thyroid cancer stem cells 03 July 2018
Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway 02 July 2018
Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma 29 June 2018
Display # 

Page 77 of 173

  • Start
  • Prev
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin and its ubiquitous anticancer effects
  • Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
  • The impact of vitamin D on cancer: A mini review
  • Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
  • An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
  • Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
  • Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
  • Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
  • Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • Bibliography
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • How effective is chemo therapy?
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Vademecum
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer